In recent years, global malaria progress has stalled. In 2024, advances were made with the widespread rollout of two malaria vaccines in sub-Saharan Africa. One of these vaccines is R21/Matrix-M and the clinical development of this malaria vaccine and latest data will be shared. In addition, thoughts on the evolving malaria landscape and future directions will be discussed.